Certior and Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence.
Cancer is a ticking time bomb globally. Every year about 18 million women and men are diagnosed with various cancers including carcinomas, sarcomas, neuroendocrine tumors, melanomas.
Trucheck™ is a blood test that can enable early detection of multiple cancers in asymptomatic individuals.
Trucheck™ Intelli is a non-invasive blood test that can detect over 70+ cancers in asymptomatic individuals.
Trucheck™ Essential Woman is a non-invasive blood test that can detect cancer in asymptomatic woman. For women over 40 years of age.
Trucheck™ Essential Man is a non-invasive blood test that can detect cancer in asymptomatic men. For men over 40 years of age.
Sem interdum a quam facilisis sollicitudin nunc bibendum enim eros arcu nis.
Ut wisi enim ad minim veniam, quis laore nostrud exerci tation ulm hedi corper turet ipsum dolor sit amet, consectetuer adipiscing elit, sed diam
Ut wisi enim ad minim veniam, quis laore nostrud exerci tation ulm hedi corper turet ipsum dolor sit amet, consectetuer adipiscing elit, sed diam
Ut wisi enim ad minim veniam, quis laore nostrud exerci tation ulm hedi corper turet ipsum dolor sit amet, consectetuer adipiscing elit, sed diam
Signup for the latest Certior news, where we’ll share updates on the latest technologies around preventative healthcare.
© 2023 Certior Health Ltd. All rights reserved
